IL108139A0 - Pharmaceutical compositions containing folic acid analogues and protecting agents - Google Patents

Pharmaceutical compositions containing folic acid analogues and protecting agents

Info

Publication number
IL108139A0
IL108139A0 IL10813993A IL10813993A IL108139A0 IL 108139 A0 IL108139 A0 IL 108139A0 IL 10813993 A IL10813993 A IL 10813993A IL 10813993 A IL10813993 A IL 10813993A IL 108139 A0 IL108139 A0 IL 108139A0
Authority
IL
Israel
Prior art keywords
folic acid
pharmaceutical compositions
compositions containing
acid analogues
protecting agents
Prior art date
Application number
IL10813993A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL108139A0 publication Critical patent/IL108139A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10813993A 1992-12-23 1993-12-22 Pharmaceutical compositions containing folic acid analogues and protecting agents IL108139A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226842A GB9226842D0 (en) 1992-12-23 1992-12-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
IL108139A0 true IL108139A0 (en) 1994-04-12

Family

ID=10727128

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10813993A IL108139A0 (en) 1992-12-23 1993-12-22 Pharmaceutical compositions containing folic acid analogues and protecting agents

Country Status (15)

Country Link
US (3) US6358952B1 (xx)
EP (1) EP0675719B1 (xx)
JP (1) JP3774850B2 (xx)
KR (1) KR100296643B1 (xx)
AT (1) ATE167058T1 (xx)
AU (1) AU676252B2 (xx)
CA (1) CA2152507C (xx)
DE (1) DE69319141T2 (xx)
ES (1) ES2117245T3 (xx)
GB (1) GB9226842D0 (xx)
IL (1) IL108139A0 (xx)
MX (1) MX9400215A (xx)
TW (1) TW340044B (xx)
WO (1) WO1994014448A1 (xx)
ZA (1) ZA939633B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
DE10062401A1 (de) * 2000-12-14 2002-06-20 Beiersdorf Ag Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
US7745930B2 (en) * 2005-04-25 2010-06-29 International Rectifier Corporation Semiconductor device packages with substrates for redistributing semiconductor device electrodes
WO2010138955A2 (en) * 2009-05-29 2010-12-02 University Of Florida Research Foundation, Inc. Methods and compositions for treating neoplasia
CN101580501B (zh) 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
DE69112376T3 (de) * 1991-03-29 2002-08-14 Lilly Co Eli Verbesserte Therapiemethode.
US5217974A (en) 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
GB9119700D0 (en) 1991-09-14 1991-10-30 Int Computers Ltd Cryptographic facility for a data processing system
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds

Also Published As

Publication number Publication date
US20030203924A1 (en) 2003-10-30
KR950703963A (ko) 1995-11-17
US6855712B2 (en) 2005-02-15
TW340044B (en) 1998-09-11
EP0675719A1 (en) 1995-10-11
KR100296643B1 (ko) 2001-10-22
DE69319141D1 (de) 1998-07-16
ES2117245T3 (es) 1998-08-01
DE69319141T2 (de) 1998-10-08
CA2152507C (en) 2005-10-18
US20020137748A1 (en) 2002-09-26
JP3774850B2 (ja) 2006-05-17
CA2152507A1 (en) 1994-07-07
US6358952B1 (en) 2002-03-19
AU5708494A (en) 1994-07-19
GB9226842D0 (en) 1993-02-17
AU676252B2 (en) 1997-03-06
EP0675719B1 (en) 1998-06-10
ATE167058T1 (de) 1998-06-15
ZA939633B (en) 1995-06-22
US6579877B2 (en) 2003-06-17
JPH08504800A (ja) 1996-05-28
WO1994014448A1 (en) 1994-07-07
MX9400215A (es) 1994-07-29

Similar Documents

Publication Publication Date Title
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
HUT67398A (en) 1h-imidazo(4,5-c)quinolin-4-amin derivatives, pharmaceutical compositions containing them
AU576563B2 (en) Pyridazine derivatives
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
CA2058428A1 (en) Analgesic formulations
ZA928771B (en) Combination chemotherapy
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
KR100257803B1 (en) Stable hydrated cephalosporin dry powder for oral suspension formulation
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
IE873125L (en) Benzimidazole derivatives
EP0620004A4 (en) MEDICAL COMPOSITION.
IL108139A0 (en) Pharmaceutical compositions containing folic acid analogues and protecting agents
HUT67287A (en) Piperazynil camphor derivatives and pharmaceutical compositions containing them
CZ123595A3 (en) The use of xanthine derivatives for preparing pharmaceutical preparations and pharmaceutical compositions containing said derivatives
AP9200443A0 (en) Heterocyclic compounds.
IL90483A0 (en) Pyridazinone derivatives,processes for their preparation,pharmaceutical compositions containing them,and their use in plant protection
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
ZA947401B (en) Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles
TR199900141T2 (xx) Bunama tedavisi ve/veya profilaksisi i�in form�lasyon.
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)